SAMANTHA ANDERS: Open Payments
NPI 1760093116 · HUNTINGDON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,698 in 105 payments from 12 companies in 2025. Trend: 2023 $898 · 2024 $1,535 · 2025 $1,698
Food & beverage: $1,614Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 35 | $551 |
| ABBVIE INC. | 31 | $455 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $208 |
| Ardelyx, Inc. | 12 | $147 |
| Aimmune Therapeutics, Inc. | 4 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Ipsen Biopharmaceuticals, Inc | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
Products named: TREMFYA, RINVOQ, ENTYVIO, IBSRELA, XIFAXAN, SKYRIZI, CREON, ZENPEP.
Industry payments across PA — which companies pay providers there.
